📖
Nanopore sequencing panel for saliva-based host pharmacogenomic screening in anti-tubercular therapy.
Yadav P, Shah SAV, Babu AS, Paradkar M, Vasanthaiah S, Vasudevan K, Arora PR, Lokhande RV, Pandya HUB, Denti P, Rodrigues C, Andrews JR, Pandey A, Tornheim JA, Ashavaid TF, Verma R, MDR-TB MUKT and RePORT India Study Teams

Nanopore sequencing panel for saliva-based host pharmacogenomic screening in anti-tubercular therapy.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in medRxiv.

Advertisement
SPONSOR CONTENT
Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Nanopore sequencing panel for saliva-based host pharmacogenomic screening in anti-tubercular therapy.
Author / Organization Yadav P, Shah SAV, Babu AS, Paradkar M, Vasanthaiah S, Vasudevan K, Arora PR, Lokhande RV, Pandya HUB, Denti P, Rodrigues C, Andrews JR, Pandey A, Tornheim JA, Ashavaid TF, Verma R, MDR-TB MUKT and RePORT India Study Teams
Subject & Discipline medRxiv
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-74866
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »